Relief Therapeutics Holding AG Cash Flow Conversion Efficiency

Latest as of June 2025: -0.115x

Relief Therapeutics Holding AG cash flow conversion efficiency. Based on the latest financial reports, Relief Therapeutics Holding AG (RLF) has a cash flow conversion efficiency ratio of -0.115x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-3.76 Million ≈ $-4.75 Million USD) by net assets (CHF32.63 Million ≈ $41.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Relief Therapeutics Holding AG (2006–2024)

Cash flow conversion efficiency of Relief Therapeutics Holding AG from 2006 to 2024. This chart illustrates how Relief Therapeutics Holding AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View RLF share price today for real-time trading data and today's change.

Relief Therapeutics Holding AG Cash Flow Conversion Ratio Explained

Relief Therapeutics Holding AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Relief Therapeutics Holding AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Relief Therapeutics Holding AG ranked by their cash flow conversion efficiency. Also see Relief Therapeutics Holding AG market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Hojeon Ltd KO:111110	0.074x
Iodm Ltd AU:IOD	1.084x
STRUCT.MONIT.SYSCDIS F:RJP	N/A
Gigas Hosting S.A MC:GIGA	0.389x
T&R Biofab Co. Ltd KQ:246710	0.002x
Tongyang Pile Inc KQ:228340	0.000x
Birlesim Muhendislik Isitma Sogutma Havalandirma Sanayi & Ticaret Sirketi AS IS:BRLSM	-0.179x
DiGiSPICE Technologies Limited NSE:DIGISPICE	0.307x

Annual Cash Flow Conversion Efficiency for Relief Therapeutics Holding AG (2006–2024)

The table below shows the annual cash flow conversion efficiency of Relief Therapeutics Holding AG from 2006 to 2024. Review RLF free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CHF36.66 Million ≈ $46.35 Million	CHF-2.92 Million ≈ $-3.69 Million	-0.080x	+76.41%
2023-12-31	CHF52.23 Million ≈ $66.03 Million	CHF-17.61 Million ≈ $-22.27 Million	-0.337x	-103.40%
2022-12-31	CHF145.42 Million ≈ $183.85 Million	CHF-24.11 Million ≈ $-30.48 Million	-0.166x	+15.73%
2021-12-31	CHF181.53 Million ≈ $229.50 Million	CHF-35.71 Million ≈ $-45.15 Million	-0.197x	+27.67%
2020-12-31	CHF67.04 Million ≈ $84.76 Million	CHF-18.23 Million ≈ $-23.05 Million	-0.272x	-419.88%
2019-12-31	CHF14.30 Million ≈ $18.08 Million	CHF-748.00K ≈ $-945.67K	-0.052x	-80.17%
2018-12-31	CHF21.28 Million ≈ $26.91 Million	CHF-618.00K ≈ $-781.32K	-0.029x	+48.15%
2017-12-31	CHF20.95 Million ≈ $26.48 Million	CHF-1.17 Million ≈ $-1.48 Million	-0.056x	+56.88%
2016-12-31	CHF22.24 Million ≈ $28.11 Million	CHF-2.89 Million ≈ $-3.65 Million	-0.130x	+65.57%
2015-12-31	CHF17.66 Million ≈ $22.32 Million	CHF-6.66 Million ≈ $-8.42 Million	-0.377x	-13.81%
2014-12-31	CHF26.35 Million ≈ $33.31 Million	CHF-8.73 Million ≈ $-11.04 Million	-0.331x	+22.01%
2013-12-31	CHF20.61 Million ≈ $26.06 Million	CHF-8.76 Million ≈ $-11.08 Million	-0.425x	-124.58%
2012-12-31	CHF-2.69 Million ≈ $-3.40 Million	CHF-4.65 Million ≈ $-5.87 Million	1.729x	+107.83%
2011-12-31	CHF464.04K ≈ $586.67K	CHF-10.24 Million ≈ $-12.95 Million	-22.075x	-6931.42%
2010-12-31	CHF52.38 Million ≈ $66.22 Million	CHF-16.44 Million ≈ $-20.79 Million	-0.314x	-437.12%
2009-12-31	CHF56.73 Million ≈ $71.73 Million	CHF-3.32 Million ≈ $-4.19 Million	-0.058x	+57.83%
2008-12-31	CHF68.94 Million ≈ $87.15 Million	CHF-9.55 Million ≈ $-12.08 Million	-0.139x	-139.60%
2007-12-31	CHF64.50 Million ≈ $81.54 Million	CHF-3.73 Million ≈ $-4.72 Million	-0.058x	-267.47%
2006-12-31	CHF66.13 Million ≈ $83.61 Million	CHF2.28 Million ≈ $2.89 Million	0.035x	--

About Relief Therapeutics Holding AG

SW:RLF Switzerland Biotechnology

Market Cap

$45.93 Million

CHF36.33 Million CHF

Market Cap Rank

#22886 Global

#204 in Switzerland

Share Price

CHF2.89

Change (1 day)

+0.87%

52-Week Range

CHF2.56 - CHF2.99

All Time High

CHF280.00